Organization Overview
aldesleukin (Proleukin) (6 trials)
autologous dendritic cells loaded with autologous tumor lysate (1 trial)
cimetidine (tagamet) (1 trial)
fluorouracil (efudex) (2 trials)
gemcitabine (gemzar) (1 trial)
interferon alpha-2b (Intron-A) (8 trials)
Carcinoid Tumor (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Esophageal Neoplasms (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 2)
Malignant Carcinoid Syndrome (Phase 2)
Melanoma (Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Penile Neoplasms (Phase 2)
Plasmacytoma (Phase 2)
Precancerous Conditions (Phase 2)
Preleukemia (Phase 2)
Skin Neoplasms (Phase 2)
Syndrome (Phase 2)
Uterine Cervical Neoplasms (Phase 2)